pioglitazone has been researched along with Animal Mammary Carcinoma in 2 studies
Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pioglitazone was administered in the diet at concentrations of 10 and 100 ppm, respectively, 12 days before the first carcinogen dose until the termination of the experiment." | 1.36 | Pioglitazone in chemically induced mammary carcinogenesis in rats. ( Ahlers, I; Ahlersová, E; Bojková, B; Garajová, M; Kajo, K; Kassayová, M; Kisková, T; Kubatka, P; Orendás, P; Péc, M, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| El-Sisi, AE | 1 |
| Sokar, SS | 1 |
| Salem, TA | 1 |
| Abu Risha, SE | 1 |
| Bojková, B | 1 |
| Garajová, M | 1 |
| Kajo, K | 1 |
| Péc, M | 1 |
| Kubatka, P | 1 |
| Kassayová, M | 1 |
| Kisková, T | 1 |
| Orendás, P | 1 |
| Ahlersová, E | 1 |
| Ahlers, I | 1 |
2 other studies available for pioglitazone and Animal Mammary Carcinoma
| Article | Year |
|---|---|
PPARγ-dependent anti-tumor and immunomodulatory actions of pioglitazone.
Topics: Animals; Apoptosis; Carcinoma, Ehrlich Tumor; Doxorubicin; Female; Gene Expression Regulation, Neopl | 2015 |
Pioglitazone in chemically induced mammary carcinogenesis in rats.
Topics: Animals; Anticarcinogenic Agents; Carcinogens; Dose-Response Relationship, Drug; Female; Mammary Neo | 2010 |